CNMV - Inside information

This website uses its own cookies and third-party cookies for technical, customisation, and analysis of behavioural advertising purposes. The latter provides data regarding browsing habits (such as the pages visited) and determine profiles to improve our content.

For further information, please read our Cookies Policy

This website contains links from third-party websites that may contain cookies not belonging to the CNMV. By viewing and accessing them, you accept the cookies installed by third parties and their corresponding privacy and cookies policy.

This website uses cookies and/or similar technologies that store and retrieve information when browsing. For further information, see our Cookies Policy

Technical cookies

Used for the website’s proper functioning.

Customisation cookies

They retrieve information in order for the user to access the service with certain characteristics that may change their experience from that of other users. For example, the language selected or other options that allow for an improved accessibility within the website.

Analytics cookies

Third party (Google). These allow for follow-up and user behaviour analysis for the purpose of incorporating improvements to the website’s content.

Behavioural advertising cookies

Third party (Google). They store information on user behaviour obtained through ongoing observation of their browsing habits, allowing for the development of a specific profile for information content optimisation.

Home >
Inside information >
Inside information

Page 21 out of 196

from 01/07/1988 to 08/09/2023

- 21/02/2023
- 08:08
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the presentation related to the 2022 full year financial results
- Register number: 1766
- 21/02/2023
- 08:06
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the press release related to the 2022 full year financial results
- Register number: 1765
- 21/02/2023
- 08:02
- LABORATORIOS FARMACEUTICOS ROVI, S.A.
- On business and financial situation
- The company releases the Integrated Report for the year 2022
- Register number: 1764
- 20/02/2023
- 18:48
- AMREST HOLDINGS, SE
- On P&L
- AmRest - Preliminary results Q4 2022
- Register number: 1763
- 20/02/2023
- 18:01
- ACS, ACTIVIDADES DE CONSTRUCCION Y SERVICIOS, S.A.
- On financial instruments
- Prórroga de un contrato forward sobre 11.968.007 acciones de ACS
- Register number: 1762
- 20/02/2023
- 06:52
- ALMIRALL, S.A.
- On P&L
- Presentation FY2022 Financial Results
- Register number: 1761
- 16/02/2023
- 09:31
- SACYR, S.A.
- On corporate transactions: mergers, acquisitions and others
- The company announces progress on the announced divestment plan.
- Register number: 1760
- - Related to communication no. 1595 dated 05/10/2022 (17:58)
- 16/02/2023
- 08:25
- PHARMA MAR, S.A.
- On business and financial situation
- The Company announces the closure of the Phase III “Neptuno” trial with plitidepsin for the treatment of COVID-19 in hospitalized patients.
- Register number: 1759
- 16/02/2023
- 07:55
- REPSOL, S.A.
- On financial instruments - On share buy-back , stabilisation and treasury stock programmes
- Proposal of share capital reduction through the redemption of 50 million own shares and implementation of a buy-back program for a maximum of 35 million shares of Repsol, S.A.
- Register number: 1758
- 15/02/2023
- 09:32
- NATURGY ENERGY GROUP, S.A.
- On P&L
- Naturgy sends FY22 results presentation
- Register number: 1757

Page 21 out of 196